GSK

Despite that sale, Theravance retained rights to receive 85% of Trelegy royalties on sales from 2029 onward outside the U.S., and from 2031 in the U.S.

These studies evaluated Blenrep combined with either bortezomib plus dexamethasone (BVd) or pomalidomide plus dexamethasone (BPd) in patients who had previously undergone at least one treatment for refractory multiple myeloma .

Blenrep is now approved in the UK for use in combination with bortezomib plus dexamethasone (BVd) in patients who have received at least one prior therapy, and in combination with pomalidomide plus dexamethasone (BPd) for those who have previously received lenalidomide.

The new US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) recommendation suggests that individuals aged 10 and older can opt for a single dose of Penmenvy instead of receiving both vaccines during the same clinic visit.

The ACIP’s recommendation was informed by positive results from a phase III clinical trial, which evaluated the immune response and safety of GSK’s RSV vaccine in adults aged 50-59, including those at higher risk due to underlying conditions.

The institute aims to provide deeper insights into biological processes and improve cancer patient outcomes by focusing on multi-omics, integrating data from genes, RNA, proteins, and metabolites.

Blujepa is specifically designed to combat uncomplicated urinary tract infections (UTIs) caused by common bacteria, including Escherichia coli, Klebsiella pneumoniae, Citrobacter freundii complex, Staphylococcus saprophyticus, and Enterococcus faecalis.

The rebranding follows GSK’s earlier decision in 2023 to shift away from direct commercial operations in Kenya and move to a distributor-led model for its prescription medicines.